(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.48%) $83.45
(-1.16%) $1.619
(-0.05%) $2 346.00
(-0.30%) $27.17
(0.21%) $924.00
(-0.05%) $0.934
(-0.15%) $11.01
(-0.06%) $0.800
(0.00%) $92.17
Quarter results tomorrow
(bmo 2024-04-29)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders...
Stats | |
---|---|
今日成交量 | 14 521.00 |
平均成交量 | 37 717.00 |
市值 | 8.74M |
EPS | €0 ( 2024-04-11 ) |
下一个收益日期 | ( €0 ) 2024-04-29 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -0.980 |
ATR14 | €0.0180 (1.59%) |
Theranexus SA 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Theranexus SA 相关性 - 货币/商品
Theranexus SA 财务报表
Annual | 2022 |
营收: | €414 898 |
毛利润: | €82 898.00 (19.98 %) |
EPS: | €-1.240 |
FY | 2022 |
营收: | €414 898 |
毛利润: | €82 898.00 (19.98 %) |
EPS: | €-1.240 |
FY | 2021 |
营收: | €0.00 |
毛利润: | €-5.55M (0.00 %) |
EPS: | €-1.622 |
FY | 2020 |
营收: | €0.00 |
毛利润: | €-3.57M (0.00 %) |
EPS: | €-1.183 |
Financial Reports:
No articles found.
Theranexus SA
Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。